SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Alibaba Health Information Technology Limited ALBBY OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • HK • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Alibaba Health Information Technology Limited (ALBBY) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $12.12. It has a SharesGrow Score of 73/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $30.6B, +14.8%/yr average growth. Net income is $1.4B, growing at +142.9%/yr. Net profit margin is 4.7% (thin). Gross margin is 24.3% (+4.3 pp trend).

Balance sheet: total debt is $36M against $16.3B equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.59 (strong liquidity). Debt-to-assets is 0.2%. Total assets: $21.2B.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 57/100 (Partial), Future ?/100 (Fail), Income 30/100 (Fail).

ALBBY SharesGrow Score Overview

75/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 75/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 57/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ALBBY

ALBBY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ALBBY: +14.8%/yr revenue is, +142.9%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ALBBY: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ALBBY: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 2.59 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

ALBBY: Gross margin is 24.3% (+4.3 pp trend), $10B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 57/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

ALBBY: Net profit margin is 4.7%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range8.95-19.45

Volume500

Avg Volume (30D)144

Market Cap$9.77B

Beta (1Y)1.69

Share Statistics

EPS (TTM)1.78

Shares Outstanding$803.53M

IPO Date2019-09-30

Employees1,422

CEODifan Shen

Financial Highlights & Ratios

Revenue (TTM)$30.6B

Gross Profit$7.43B

EBITDA$1.62B

Net Income$1.43B

Operating Income$1.58B

Total Cash$8.1B

Total Debt$35.52M

Net Debt$-2.18B

Total Assets$21.18B

Price / Earnings (P/E)6.8

Price / Sales (P/S)0.32

Analyst Forecast

Company Info

CountryHK

ExchangeOther OTC

CurrencyUSD

ISINUS01609Y1082

Price Chart

ALBBY

Alibaba Health Information Technology Limited ↗ · Other OTC

Healthcare • Medical - Pharmaceuticals

8.95 52WK RANGE 19.45

People Also View

Walgreens Boots Alliance, Inc.

Alibaba Health Information Technology Limited

PetMed Express, Inc.

Rite Aid Corporation

China Jo-Jo Drugstores, Inc.

Alternative Energy Partners, Inc.

Decision Diagnostics Corp.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message